Epigenetics-focused biotech Constellation raises $100mConstellation Pharmaceuticals, a company focused on developing small molecule therapies for difficult-to-treat cancers has raised $100 million from a group of old and new investors. Share XEpigenetics-focused biotech Constellation raises $100mhttps://pharmaphorum.com/news/epigenetics-focused-biotech-constellation-raises-100m/